Drug intelligence / Profile preview

salidroside

Development stage
Phase 2
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Salidroside is a phenylethanoid glycoside and the primary active compound found in Rhodiola rosea (commonly known as golden root or 红景天). It is a glucoside of tyrosol. Salidroside has been studied for its broad spectrum of pharmacological activities including antioxidant, anti-inflammatory, neuroprotective, anti-fatigue, anti-aging effects and potential antitumor properties. Mechanistically it modulates multiple signaling pathways such as PI3K/Akt/mTOR and JAK2/STAT3 to exert cytoprotective effects against oxidative stress and inflammation. It also inhibits pro-inflammatory cytokines via NF-κB/MAPK pathways and promotes apoptosis in cancer cells by regulating proteins like Bax/Bcl-2/caspases. Preclinical studies suggest benefits in metabolic disorders (e.g., improving glucose homeostasis), cardiovascular protection under hypoxic conditions, neuroprotection (including cognitive improvement at high altitude), and as an adjuvant to sensitize tumor cells to chemo/radiotherapy by reducing HIF-1α expression[2][6][7][9][10].

Other names
rhodiolosiderhodosin2-(4-hydroxyphenyl)ethyl β-D-glucopyranosidealidrosideSALIDROSIDE(P)Salidroside-RMRHODIOLAEXTRACT红景天苷
02

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)NF-κBAKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)mTOR (Mammalian target of rapamycin kinase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on salidroside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salidroside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call